MOSES-assisted versus conventional holmium laser enucleation of the prostate for benign prostatic hyperplasia: a pooled study
Authors:
Open Access
- 14 October 2026
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 13, 1946428
Abstract
Purpose: With the widespread adoption of holmium laser enucleation of the prostate (HoLEP), increasing attention has focused on whether pulse-modulation technologies can further improve procedural efficiency and perioperative outcomes. We therefore conducted an updated systematic review and meta-analysis comparing MOSES-assisted HoLEP (MoLEP) with conventional HoLEP for benign prostatic hyperplasia (BPH). Methods: PubMed, Embase, Web of Science, and the ClinicalTrials.gov were searched through September 2026 for comparative studies evaluating MoLEP versus conventional HoLEP. Study selection and data extraction were performed according to predefined criteria. Pooled analyses were conducted using R (version 4.4.1), with subgroup and sensitivity analyses undertaken where appropriate. Results: Ten studies comprising 3,177 patients (1,599 MoLEP and 1,578 conventional HoLEP) were included. MoLEP was associated with shorter enucleation time (MD −7.45 min, 95% CI −11.05 to −3.85; P < 0.001), hemostasis time (MD −3.79 min, 95% CI −5.93 to −1.65; P < 0.001), and operative time (MD −12.09 min, 95% CI −18.01 to −6.18; P < 0.001). No significant between-group differences were observed in enucleated weight (MD 1.01 g, 95% CI −3.20–5.21; P = 0.639), catheterization time (SMD −0.13, 95% CI −0.35–0.09; P = 0.238), or length of stay (SMD −0.23, 95% CI −0.52–0.05; P = 0.113). MoLEP was associated with a generally lower incidence of postoperative complications than conventional HoLEP ( P < 0.001). Regarding functional outcomes, statistically significant between-group differences were observed in PVR at 1 and 6 months, QoL at 3 months, and IPSS at 6 months, whereas other functional outcomes did not differ significantly between groups. Conclusions: The current evidence suggests that MoLEP may improve perioperative efficiency and reduce postoperative complications, while early functional outcomes remain broadly comparable with conventional HoLEP. Further high-quality studies with longer follow-up are needed to confirm these potential benefits. Systematic Review Registration: ID: CRD420251177474.Keywords
This publication has 38 references indexed in Scilit:
- Impact of Moses technology on HoLEP day-case success rate: a monocentric matched paired cohort studyWorld Journal of Urology, 2026
- Impact of pulse modulation technology on operating room time and blood loss in HoLEP: real-world data from an academic centerLasers in Medical Science, 2026
- Thulium Fiber Versus Holmium:Yttrium-aluminum-garnet Laser for Endoscopic Enucleation of the Prostate: A Systematic Review and Meta-analysisEuropean Urology Focus, 2024
- Pulse modulation in En-Bloc HoLEP: does it really matter? A propensity score matched analysisWorld Journal of Urology, 2024
- Histopathological assessment of depth of coagulation necrosis with Holmium, Moses, and Thulium fiber lasers in human prostate tissueWorld Journal of Urology, 2023
- En Bloc enucleation with early apical release technique using MOSES (En Bloc MoLEP) vs. classic En Bloc HoLEP: a single arm study comparing intra- and postoperative outcomesWorld Journal of Urology, 2022
- Efficiency and clinical outcomes of Moses technology for holmium laser enucleation of the prostate: An evidence‐based analysisThe Prostate, 2022
- Comparative efficacy and safety of holmium laser enucleation of the prostate (HoLEP) using moses technology and standard HoLEP: A systematic review, meta-analysis, and meta-regressionAnnals of Medicine & Surgery, 2022
- Does MOSES Technology Enhance the Efficiency and Outcomes of Standard Holmium Laser Enucleation of the Prostate? Results of a Systematic Review and Meta-analysis of Comparative StudiesEuropean Urology Focus, 2022
- Validation of the Clavien–Dindo Grading System in Urology by the European Association of Urology Guidelines Ad Hoc PanelEuropean Urology Focus, 2018